US Equities Analysis

ZTS — Zoetis

ZTS ZTS Price Chart

Zoetis (ZTS) is a pharmaceuticals company in the Health Care sector. Listed on the NASDAQ, Zoetis is a component of the S&P 500 index. As of 2026-06-10, the stock is trading at $81.29.

Key Metrics & Risk

Based on 5-year historical data from Yahoo Finance (daily returns, annualized using 252 trading days).

MetricValue
Latest Price$81.29
Latest Date2026-06-10
Expected Return (Annualized)-10.95%
Risk / Std Dev (Annualized)28.78%
Sharpe Ratio (rf=4.5%)-0.54

S&P 500 Context

  • Sector: Health Care
  • Sub-Industry: Pharmaceuticals
  • Exchange: NASDAQ
  • Index: S&P 500 Component

Risk/Return Profile

The stock shows an annualized expected return of -10.95% with an annualized volatility of 28.78%. The Sharpe ratio of -0.54 (assuming 4.5% risk-free rate) indicates negative risk-adjusted returns relative to the risk-free rate.

Modern Portfolio Theory Positioning

This stock is plotted on the S&P 500 Modern Portfolio Theory chart which visualizes the risk/return trade-off across all S&P 500 components. The chart uses Sharpe ratio as the color dimension, allowing quick identification of stocks with superior risk-adjusted performance.

Fundamentals

MetricValue
Market Cap34.08B
Enterprise Value41.39B
Trailing P/E13.33
Forward P/E10.95
Price to Book10.37
Price to Sales3.58
EV/Revenue4.34
EV/EBITDA10.16

| Profitability | | | Profit Margin | 28.04% | | Operating Margin | 36.56% | | ROE | 67.75% | | ROA | 15.53% |

| Growth | | | Revenue Growth | 2.9% | | Earnings Growth | 6.0% |

| Dividend | | | Dividend Yield | 261.0% | | Payout Ratio | 33.28% | | 5Y Avg Yield | 95.0% |

| Financial Health | | | Total Revenue | 9.53B | | Total Debt | 9.25B | | Total Cash | 1.94B | | Free Cash Flow | 1.78B | | Operating Cash Flow | 2.79B |

| Price & Technical | | | 52W High | $168.83$ | | 52W Low | $72.38$ | | 50-Day Avg | $99.68$ | | 200-Day Avg | $123.36$ | | Beta | 0.74 | | Shares Outstanding | 0.42B | | Float Shares | 0.42B | | Insider Holdings | 0.15% | | Institutional Holdings | 102.91% | | Short Ratio | 1.45 | | Short % of Float | 3.63% |

| Analyst Targets | | | Target High | $160.0$ | | Target Low | $90.0$ | | Target Mean | $124.59$ | | Target Median | $130.0$ | | # of Analysts | 17 | | Recommendation | buy |

Disclaimer

This analysis is for educational purposes only and does not constitute financial advice. Past performance is not indicative of future results. Always conduct your own research or consult a qualified financial advisor before making investment decisions.

us-equity stock equity zts health-care pharmaceuticals nasdaq